- Home
- MRNA vs BKR Comparison
MRNA vs BKR Comparison
Compare MRNA & BKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | BKR |
|---|---|---|
| Founded | 2010 | 2016 |
| Country | United States | United States |
| Employees | N/A | 64000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6B | 62.0B |
| IPO Year | 2018 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MRNA | BKR |
|---|---|---|
| Price | $198.47 | $56.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $34.27 | ★ $67.25 |
| AVG Volume (30 Days) | ★ 13.5M | 7.2M |
| Earning Date | 05-01-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.34% |
| EPS Growth | 21.77 | ★ 56.02 |
| EPS | N/A | ★ 2.98 |
| Revenue | $19,263,000,000.00 | ★ $27,733,000,000.00 |
| Revenue This Year | $9.36 | $0.62 |
| Revenue Next Year | $15.43 | $7.15 |
| P/E Ratio | ★ N/A | $19.17 |
| Revenue Growth | ★ 4.29 | N/A |
| 52 Week Low | $22.28 | $43.92 |
| 52 Week High | $202.67 | $70.41 |
Technical Indicators
Market Signals| Indicator | MRNA | BKR |
|---|---|---|
| Relative Strength Index (RSI) | 75.87 | 35.66 |
| Support Level | $43.35 | $53.51 |
| Resistance Level | N/A | $64.95 |
| Average True Range (ATR) | 11.47 | 1.74 |
| MACD | 2.59 | -0.16 |
| Stochastic Oscillator | 86.71 | 12.50 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About BKR Baker Hughes Company
Following a 2022 reorganization, Baker Hughes operates in two segments: oilfield services and equipment, and industrial and energy technology. The firm's oilfield services and equipment segment is one of the Big Three oilfield-services players, along with SLB and Halliburton, and mostly supplies to hydrocarbon developers and producers, including national oil companies, major integrated firms, and independents. Markets outside of North America buy roughly three-fourths of the segment's offerings. Baker Hughes' industrial and energy technology segment manufactures and sells turbines, compressors, pumps, valves, and related testing and monitoring services for various energy and industrial applications.